Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: An updated systematic review of randomized controlled trialsAlessandro Mantovani, Giovanni Targher, Christopher D. Byrne et al.|Diabetes & Metabolism|2020Cited by 140
Association of Statin Use With Risk of Liver Disease, Hepatocellular Carcinoma, and Liver-Related MortalityMara Sophie Vell, Carolin V. Schneider, Jonel Trebicka et al.|JAMA Network Open|2023Cited by 108